Quantitative variations in the expression of H-2 antigens on murine leukemia virus-induced tumor cells can affect the H-2 restriction patterns of tumor-specific cytolytic T lymphocytes
暂无分享,去创建一个
J. Levy | A. Tilkin | F. Plata | F. Lilly | Fernando Plata | ANNE-FRANOISE Tilkin | JEAN-PAUL Livy | ANn Frank Lilly
[1] W. Bodmer,et al. Lack of expression of HLA antigens on choriocarcinoma cell lines. , 2008, Tissue antigens.
[2] A. Weiss,et al. Antigenic specificity of the cytolytic T lymphocyte response to murine sarcoma virus-induced tumors. III. Characterization of cytolytic T lymphocyte clones specific for Moloney leukemia virus-associated cell surface antigens , 1980, The Journal of experimental medicine.
[3] S. Emerson,et al. Selective turnover and shedding of H-2K and H-2D antigens is controlled by the major histocompatibility complex. Implications for H-2- restricted recognition , 1980, The Journal of experimental medicine.
[4] W. Green,et al. Specificity of cytolytic T cells directed against AKR/Gross virus-induced syngeneic leukemias: antibodies directed against H-2K, but not against viral proteins, inhibit lysis. , 1980, Journal of immunology.
[5] J. Levy,et al. Immune response genes control T killer cell response against Moloney tumor antigen cytolysis regulating reactions against the best available H-2 + viral antigen association , 1980, The Journal of experimental medicine.
[6] I. Weissman,et al. T cell maturation: thymocyte and thymus migrant subpopulations defined with monoclonal antibodies to MHC region antigens. , 1980, Journal of immunology.
[7] L. Gooding. Anomalous behavior of H-2Kb in immunity to syngeneic SV40 transformed cells: evidence for cytotoxic T cell recognition of H-2/SV40 membrane antigen complexes. , 1980, Journal of immunology.
[8] M. Goodenow,et al. Studies of cloned Friend erythroleukemia tumor cells. Modulation of the tumor-specific cytologic T lymphocyte response by infectious Friend virus production in vitro , 1980, The Journal of experimental medicine.
[9] F. Plata,et al. Viral specificity of H-2-restricted T killer cells directed against syngeneic tumors induced by Gross, Friend, or Rauscher leukemia virus , 1979, The Journal of experimental medicine.
[10] T. Taniyama,et al. Requirement of histocompatible macrophages for the induction of a secondary cytotoxic response to syngeneic tumor cells in vitro. , 1979, Journal of immunology.
[11] L. Gooding. Antibody blockade of lysis by T lymphocyte effectors generated against syngeneic SV40 transformed cells. , 1979, Journal of immunology.
[12] D. Meruelo,et al. A role for elevated H-2 antigen expression in resistance to neoplasia caused by radiation-induced leukemia virus. Enhancement of effective tumor surveillance by killer lymphocytes , 1979, The Journal of experimental medicine.
[13] J. Klein,et al. Ir-genes in H-2 regulate generation of anti-viral cytotoxic T cells. Mapping to K or D and dominance of unresponsiveness , 1978, The Journal of experimental medicine.
[14] J. Bennink,et al. Cytotoxic T-cell responses in mice infected with influenza and vaccinia viruses vary in magnitude with H-2 genotype , 1978, The Journal of experimental medicine.
[15] K. Blank,et al. Evidence for an H–2/viral protein complex on the cell surface as the basis for the H–2 restriction of cytotoxicity , 1977, Nature.
[16] T. Rème,et al. Exclusive involvement of H-2D(b) or H-2K(d) product in the interaction between T-killer lymphocytes and syngeneic H-2(b) or H-2(d) viral lymphomas , 1977, The Journal of experimental medicine.
[17] F. Lilly,et al. Selective incorporation of H–2 antigenic determinants into Friend virus particles , 1977, Nature.
[18] V. Jongeneel,et al. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus‐induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells , 1976, European journal of immunology.
[19] G. Trinchieri,et al. Cell-mediated cytotoxicity to SV40-specific tumour-associated antigens , 1976, Nature.
[20] B. Chesebro,et al. Studies on the role of the host immune response in recovery from Friend virus leukemia. II. Cell-mediated immunity , 1976, The Journal of experimental medicine.
[21] B. Benacerraf,et al. Inhibition of T-lymphocyte-mediated tumor-specific lysis by alloantisera directed against the H-2 serological specificities of the tumor , 1975, The Journal of experimental medicine.
[22] F. Lilly,et al. Properties of cell lines derived from tumors induced by Friend virus in BALB/c and BALB/c-H-2b mice , 1975, The Journal of experimental medicine.
[23] M. Raff,et al. Redistribution and pinocytosis of lymphocyte surface immunoglobulin molecules induced by anti-immunoglobulin antibody. , 1971, Nature: New biology.
[24] K. Vickerman,et al. Localization of Variable Antigens in the Surface Coat of Trypanosoma brucei using Ferritin Conjugated Antibody , 1969, Nature.
[25] J. Sommerville. Serotype transformation in Paramecium aurelia: antigen synthesis after a temperature change. , 1969, Experimental cell research.
[26] L. Old,et al. ANTIGENIC MODULATION , 1968, The Journal of experimental medicine.
[27] B. Chapuis,et al. Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. , 1968, Immunology.
[28] A. Sanderson. Quantitative titration, kinetic behaviour, and inhibition of cytotoxic mouse isoantisera. , 1965, Immunology.
[29] L. Old,et al. The G (Gross) leukemia antigen. , 1965, Cancer research.
[30] L. Gross,et al. Development and Serial Cell-Free Passage of a Highly Potent Strain of Mouse Leukemia Virus.∗ , 1957, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.